Page 1 - hypertension_newsletter6

REFLECTIONS
Hypertension
Hypertension Global Newsletter #6 2024

TABLE OF CONTENTS

KEY ARTICLES
Welcome back to the REFLECTIONS Hypertension
EPIDEMIOLOGY Global Newsletter series, which draws on the Hypertension
Global report on hypertension: The race against expertise of international physicians to summarise
a silent killer. World Health Organization. 2023. the latest clinical and real-world evidence in the
field of hypertension and reflect on the clinical
MODIFIABLE RISK FACTORS
impact of these new data on the management of
Global effect of modifiable risk factors on patients with hypertension. This time, our articles
cardiovascular disease and mortality. Global will focus on 1) epidemiology, 2) modifiable risk
Cardiovascular Risk Consortium. N Engl J Med.
2023 Oct 5;389(14):1273-1285. factors, and 3) treatment and adherence. On behalf
of the Scientific Planning Committee (SPC), I invite
Lifestyle management of hypertension: you to interact with this newsletter through links to
International Society of Hypertension position
paper endorsed by the World Hypertension commentary videos from authors of the publications
League and European Society of Hypertension. and short video clinical perspectives from our SPC,
Charchar FJ, et al. J Hypertens. 2024 Jan and delve into the articles through hyperlinks for
1;42(1):23-49. in-depth study. A new feature in this newsletter is
TREATMENT AND ADHERENCE our Conference Corner, where we highlight some
abstracts of interest from the recent 2023 ESC
Systolic blood pressure time in target range
and incident atrial fibrillation in patients with Conference in Amsterdam
hypertension: Insights from the SPRINT trial. Prof. Laurent (Chair)
Wang J, et al. Hypertension. 2023 Nov;80(11):2306-
2314.
Randomized clinical outcome trials in
hypertension. Mancia G, Kjeldsen SE. SCIENTIFIC PLANNING COMMITTEE
Hypertension. 2024 Jan;81(1):17-23.

A practical approach to assessment of non- Prof. Stéphane Laurent Prof. Diego Araiza
adherence to antihypertensive treatment. (France) (Mexico)
Kociánová E, et al. J Hypertens. 2023 Sep
1;41(9):1371-1375.
A real-world analysis of outcomes and
healthcare costs of patients on perindopril/ Prof. Adriana Camargo Dr. Om Narayan
(Brazil)
(Australia)
indapamide/amlodipine single-pill vs. multiple-
pill combination in Italy. J Hypertens. 2024 Jan
1;42(1):136-142.
ADDITIONAL ARTICLES OF INTEREST Prof. Nqoba Tsabedze Dr. Michal Fikrle
(South Africa)
(Czech Republic)
CONFERENCE CORNER

HIGHLIGHTED ABSTRACTS OF INTEREST
FROM THE ESC 2023 CONFERENCE.